Founded in 2013, COMMPAZZ has emerged to supply the absence of export, import and communication services in the pet market. In order to develop these services, we believe that the professionalization and qualification of the sector was essential to reach new markets. Our company innovates bringing a concept of intelligent, personalized and affordable solutions. We carry out everything from structuring the company’s export department to tracking the product in the target market. We believe that our expertise, coupled with a new way of delivering results, contributes to the development of the international pet market.
Coder Ivy
Coder Ivy is a Brazilian technology company focused on hyper-personalization for e-commerce, helping digital retailers transform large volumes of customer data into more relevant, engaging, and profitable shopping journeys. What Coder Ivy Does Recommendation Engine (CoderAI) A behavioral artificial intelligence system that generates highly personalized, real-time product recommendations based on each customer’s browsing and purchasing behavior. Main Products CoderShelf – Plug-and-play recommendation carousels with up to 10 different algorithms (e.g., “BySimilarity,” “Popular,” “ByRelevance”), which can be applied to the homepage, product detail pages (PDP), and cart. These carousels increase average order value and revenue per customer. CoderApp – A white-label mobile app for retailers, equipped with personalized recommendations, smart push notifications, geolocation, and more than 130 features for direct engagement. CoderEngage – A customer data platform (CDP) and omnichannel orchestration tool, connecting different touchpoints and enabling seamless experiences across web, app, and marketing channels.
Centroflora Group
With 65 years of history, Centroflora Group maintains its tradition as a manufacturer of botanical extracts, essential oils and isolated actives (APIs) for the pharmaceutical industry. Grupo Centroflora considers innovation as the key to its growth, through differentiated and competitive processes and products. | Centroflora Group has spared no efforts in valuing Brazilian biodiversity as a source of Innovation for the Phytomedicines market. With 64 years of history, Centroflora maintains its tradition as a manufacturer of botanical extracts, essential oils and isolated ingredients for the pharmaceutical industry. In recent years, it has also been consolidating itself as a national manufacturer of Active Pharmaceutical Ingredients (APIs), through new partnerships and investments to adapt its production and commercial structure. Centroflora has technologies and processes that allow the isolation, extraction, concentration and drying of differentiated natural assets, with assured quality and traceability. As a result, it offers the market a wide variety of extracts from different regions of the planet, with special attention to those derived from Brazilian biodiversity, with total sustainability and respect for the environment; in other words, Centroflora has always acted in line with the principles that today are known as ESG.
Centralsul Car Care
Centralsul Car Care was created in 1995 with the objective of manufacture products for automotive beauty. Initially the company turned its efforts to service in the state of Rio Grande do Sul and gradually expanded its scope to all states of Brazil. In order to diversify its products, the company is constantly updating its products and business Portfolio. Our focus of service is retail, self service, conveniences and auto parts. In recent years, Centralsul has acquired state-of-the-art equipment for the manufacture of its products, its professionals are highly qualified to offer its customers the highest quality products, we have a high-tech testing laboratory, thus allowing us to create products within the established standards by Anvisa and required by the consumer.
Celluris
Celluris is the first Latin American company developing personalized treatment for cancer patients through CAR-T immunotherapy for Solid Tumors. This technique is based on the modification of the patient’s cells into recognizing the tumor as a target, fighting it accurately. Celluris’ novel solution, RfuCAR, was engineering to respond to some challenges in the field. RfuCAR is a bispecific receptor CAR, composed by an antigen binding domain and another domain that binds to an extracellular molecule from tumoral microenvironment. Therefore, RfuCAR can modulate the tumoral microenvironment by trapping an extracellular molecule, reducing inhibitory signaling and improving the CAR anti-tumoral function. In addition, our platform encompasses a switch on/off/modulation system to control toxicity, so with administration of small peptides that will block CAR epitopes, it will be possible to minimize the effects of CRS and neurotoxicity, very common in patients treated with CAR-T therapy. Our first targets will be lung, pancreatic and mesothelioma tumors, we already obtained some encouraging in vitro data, showing almost 30% of tumoral epithelial cells killing. With P&D located in São Paulo, Brazil, and with office in US, Celluris was co-founded by Yechiel Stern and Patricia Rozenchan.
Cellertz
Cellertz Bio is an mRNA therapeutics company combining cutting-edge artificial intelligence and physics-based models to unlock the full potential of mRNA medicines. Our proprietary platform systematically explores the vast mRNA sequence space to design optimized mRNA molecules with superior stability, translation efficiency, and protein expression—enabling a new generation of high-performance mRNA therapies. Beyond platform licensing, Cellertz is building a differentiated therapeutic pipeline focused on in vivo immune cell engineering to treat cancer and autoimmune diseases. These programs offer scalable, off-the-shelf alternatives to cell therapies and can be monetized through strategic partnerships, co-development deals, or out-licensing. With a dual business model spanning platform and therapeutic pipeline, Cellertz is uniquely positioned to create value at the intersection of AI, synthetic biology, and next-generation immunotherapy.
Celidonio & Migliori Propriedade Intelectual LTDA
With broad and consolidated experience, Celidonio and Migliori is your partner to strengthen your ideas. With global reach, we can help protect your innovation and provide strategic from distinctive perspectives involving your Intellectual Property portfolio, advice on patents, trademarks, designs, and IP matters. Together we can face the challenges of the transforming world and be the agents of creation.